Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscle, Skeletal | 25 | 2024 | 473 | 5.060 |
Why?
|
Muscular Dystrophy, Duchenne | 10 | 2024 | 35 | 3.020 |
Why?
|
Annexin A6 | 6 | 2022 | 10 | 2.200 |
Why?
|
Muscular Dystrophies | 7 | 2024 | 55 | 2.070 |
Why?
|
Muscle Proteins | 8 | 2021 | 132 | 2.060 |
Why?
|
Cell Membrane | 9 | 2021 | 683 | 1.950 |
Why?
|
Membrane Proteins | 11 | 2021 | 1232 | 1.920 |
Why?
|
Muscular Dystrophy, Animal | 8 | 2019 | 21 | 1.810 |
Why?
|
Muscle Fibers, Skeletal | 6 | 2019 | 51 | 1.740 |
Why?
|
Immunoglobulin G | 6 | 2023 | 472 | 1.710 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 6 | 2024 | 15 | 1.430 |
Why?
|
Dysferlin | 6 | 2024 | 14 | 1.350 |
Why?
|
Calcium | 4 | 2022 | 1183 | 1.170 |
Why?
|
Mice, Inbred mdx | 5 | 2024 | 13 | 1.150 |
Why?
|
Muscle Development | 6 | 2019 | 41 | 1.120 |
Why?
|
Dried Blood Spot Testing | 3 | 2021 | 10 | 1.090 |
Why?
|
Vesicular Transport Proteins | 3 | 2015 | 66 | 1.020 |
Why?
|
Muscles | 3 | 2024 | 192 | 0.970 |
Why?
|
Disease Models, Animal | 8 | 2024 | 2409 | 0.960 |
Why?
|
Vaccines, Synthetic | 2 | 2021 | 56 | 0.940 |
Why?
|
Mice | 28 | 2025 | 11949 | 0.880 |
Why?
|
Myoblasts | 7 | 2024 | 32 | 0.810 |
Why?
|
Sarcolemma | 10 | 2019 | 31 | 0.810 |
Why?
|
Animals | 37 | 2025 | 27715 | 0.810 |
Why?
|
Sarcoglycans | 7 | 2024 | 14 | 0.800 |
Why?
|
Membrane Fusion | 3 | 2021 | 38 | 0.780 |
Why?
|
Neuromuscular Diseases | 1 | 2021 | 31 | 0.770 |
Why?
|
Excitation Contraction Coupling | 1 | 2021 | 8 | 0.760 |
Why?
|
Myocytes, Cardiac | 8 | 2024 | 316 | 0.760 |
Why?
|
Biomarkers | 3 | 2024 | 1800 | 0.760 |
Why?
|
Family Characteristics | 2 | 2022 | 49 | 0.750 |
Why?
|
Serologic Tests | 2 | 2021 | 43 | 0.750 |
Why?
|
Annexins | 2 | 2022 | 6 | 0.740 |
Why?
|
Pandemics | 5 | 2023 | 789 | 0.690 |
Why?
|
Induced Pluripotent Stem Cells | 5 | 2024 | 128 | 0.680 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2010 | 115 | 0.660 |
Why?
|
Gene Editing | 1 | 2019 | 50 | 0.650 |
Why?
|
Exons | 3 | 2019 | 453 | 0.650 |
Why?
|
Spike Glycoprotein, Coronavirus | 5 | 2022 | 45 | 0.640 |
Why?
|
Antibodies, Viral | 6 | 2022 | 311 | 0.610 |
Why?
|
Health Personnel | 1 | 2020 | 216 | 0.600 |
Why?
|
Muscle Cells | 1 | 2017 | 18 | 0.570 |
Why?
|
Betacoronavirus | 1 | 2020 | 264 | 0.560 |
Why?
|
Prednisone | 4 | 2024 | 254 | 0.550 |
Why?
|
Protein Transport | 8 | 2016 | 426 | 0.550 |
Why?
|
Health | 1 | 2015 | 29 | 0.510 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 321 | 0.490 |
Why?
|
Coronavirus Infections | 1 | 2020 | 307 | 0.490 |
Why?
|
Disease | 1 | 2015 | 90 | 0.480 |
Why?
|
Neutralization Tests | 4 | 2022 | 80 | 0.480 |
Why?
|
Glucocorticoids | 5 | 2024 | 359 | 0.470 |
Why?
|
Muscular Diseases | 3 | 2023 | 64 | 0.460 |
Why?
|
Dynamin II | 1 | 2014 | 15 | 0.460 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2014 | 10 | 0.460 |
Why?
|
Quadriceps Muscle | 1 | 2014 | 5 | 0.450 |
Why?
|
Proteostasis | 2 | 2024 | 12 | 0.450 |
Why?
|
Male | 20 | 2025 | 42967 | 0.440 |
Why?
|
Glycerol | 1 | 2013 | 35 | 0.440 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 3486 | 0.420 |
Why?
|
Actins | 1 | 2016 | 469 | 0.420 |
Why?
|
Antibodies, Neutralizing | 3 | 2022 | 124 | 0.400 |
Why?
|
Fibrosis | 4 | 2023 | 238 | 0.400 |
Why?
|
Mice, Knockout | 6 | 2024 | 2042 | 0.400 |
Why?
|
Gene Expression | 3 | 2019 | 1313 | 0.390 |
Why?
|
Antibody Formation | 2 | 2021 | 172 | 0.370 |
Why?
|
Seroepidemiologic Studies | 2 | 2021 | 55 | 0.360 |
Why?
|
Mice, 129 Strain | 3 | 2021 | 57 | 0.360 |
Why?
|
RNA, Messenger | 3 | 2019 | 2034 | 0.350 |
Why?
|
NFATC Transcription Factors | 1 | 2010 | 49 | 0.350 |
Why?
|
Mice, Inbred C57BL | 7 | 2025 | 3278 | 0.340 |
Why?
|
Latent TGF-beta Binding Proteins | 2 | 2021 | 4 | 0.340 |
Why?
|
Receptor, IGF Type 1 | 1 | 2009 | 45 | 0.340 |
Why?
|
DNA | 1 | 2015 | 1314 | 0.340 |
Why?
|
Female | 16 | 2025 | 46894 | 0.330 |
Why?
|
Wound Healing | 4 | 2016 | 365 | 0.330 |
Why?
|
Humans | 29 | 2024 | 90640 | 0.310 |
Why?
|
Extracellular Matrix | 3 | 2024 | 248 | 0.300 |
Why?
|
Young Adult | 5 | 2024 | 6426 | 0.280 |
Why?
|
Carrier Proteins | 3 | 2021 | 679 | 0.280 |
Why?
|
Vaccination | 3 | 2023 | 280 | 0.250 |
Why?
|
Myosin Type V | 1 | 2025 | 13 | 0.250 |
Why?
|
Cells, Cultured | 6 | 2018 | 2895 | 0.240 |
Why?
|
Regeneration | 3 | 2017 | 151 | 0.240 |
Why?
|
Myosin Heavy Chains | 1 | 2025 | 92 | 0.240 |
Why?
|
Middle Aged | 7 | 2024 | 26347 | 0.230 |
Why?
|
Immunoblotting | 2 | 2016 | 272 | 0.230 |
Why?
|
Adult | 7 | 2024 | 26953 | 0.230 |
Why?
|
Filamins | 1 | 2024 | 22 | 0.230 |
Why?
|
Cardiomyopathies | 2 | 2024 | 270 | 0.230 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2024 | 44 | 0.230 |
Why?
|
Myocarditis | 1 | 2024 | 52 | 0.220 |
Why?
|
Mice, Inbred DBA | 6 | 2024 | 150 | 0.220 |
Why?
|
Mice, Mutant Strains | 2 | 2016 | 231 | 0.210 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2015 | 315 | 0.210 |
Why?
|
Tumor Suppressor Proteins | 2 | 2015 | 290 | 0.200 |
Why?
|
Tissue Engineering | 1 | 2024 | 196 | 0.200 |
Why?
|
Mice, Transgenic | 4 | 2022 | 1583 | 0.200 |
Why?
|
Calcium-Binding Proteins | 2 | 2021 | 121 | 0.200 |
Why?
|
Immunologic Tests | 1 | 2021 | 6 | 0.190 |
Why?
|
Monocytes | 1 | 2023 | 222 | 0.190 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 511 | 0.190 |
Why?
|
Drug Interactions | 1 | 2021 | 244 | 0.190 |
Why?
|
Mitochondria | 1 | 2025 | 562 | 0.180 |
Why?
|
Extracellular Vesicles | 1 | 2022 | 42 | 0.180 |
Why?
|
Heart Diseases | 1 | 2023 | 306 | 0.180 |
Why?
|
Cell Differentiation | 2 | 2024 | 1553 | 0.180 |
Why?
|
Steroids | 1 | 2021 | 173 | 0.180 |
Why?
|
Genes, Modifier | 2 | 2017 | 5 | 0.180 |
Why?
|
Immunity, Innate | 1 | 2024 | 437 | 0.180 |
Why?
|
Muscle Contraction | 1 | 2021 | 286 | 0.180 |
Why?
|
Cell Movement | 1 | 2024 | 793 | 0.170 |
Why?
|
Chicago | 2 | 2021 | 1441 | 0.170 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 374 | 0.160 |
Why?
|
Lysosomes | 2 | 2010 | 116 | 0.160 |
Why?
|
Myotonic Dystrophy | 1 | 2019 | 7 | 0.160 |
Why?
|
Mutation | 4 | 2025 | 4183 | 0.160 |
Why?
|
MyoD Protein | 1 | 2019 | 16 | 0.160 |
Why?
|
Dual Specificity Phosphatase 6 | 1 | 2019 | 1 | 0.160 |
Why?
|
Transforming Growth Factor beta | 1 | 2021 | 326 | 0.160 |
Why?
|
Point Mutation | 1 | 2019 | 246 | 0.160 |
Why?
|
Signal Transduction | 1 | 2009 | 3431 | 0.160 |
Why?
|
Sarcoglycanopathies | 1 | 2018 | 2 | 0.150 |
Why?
|
Severity of Illness Index | 1 | 2024 | 1882 | 0.150 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 123 | 0.150 |
Why?
|
Morpholinos | 1 | 2018 | 13 | 0.150 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2024 | 1259 | 0.150 |
Why?
|
Dystrophin | 4 | 2024 | 22 | 0.150 |
Why?
|
Adolescent | 2 | 2021 | 9354 | 0.150 |
Why?
|
Phenotype | 1 | 2024 | 2473 | 0.150 |
Why?
|
Osteopontin | 1 | 2017 | 47 | 0.140 |
Why?
|
Recombinant Proteins | 1 | 2019 | 1015 | 0.140 |
Why?
|
Protein Binding | 4 | 2022 | 1500 | 0.140 |
Why?
|
Phospholipids | 1 | 2017 | 112 | 0.140 |
Why?
|
Genetic Therapy | 2 | 2018 | 373 | 0.140 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 2019 | 0.130 |
Why?
|
Exosomes | 1 | 2017 | 55 | 0.130 |
Why?
|
Microscopy, Fluorescence | 2 | 2018 | 441 | 0.130 |
Why?
|
Cell Communication | 1 | 2017 | 202 | 0.130 |
Why?
|
Dystrophin-Associated Protein Complex | 1 | 2015 | 3 | 0.130 |
Why?
|
Electroporation | 1 | 2015 | 58 | 0.130 |
Why?
|
Base Sequence | 1 | 2019 | 2329 | 0.130 |
Why?
|
Transcription Factors | 1 | 2024 | 1670 | 0.130 |
Why?
|
Creatine Kinase | 1 | 2015 | 53 | 0.130 |
Why?
|
Oligonucleotides, Antisense | 1 | 2015 | 67 | 0.130 |
Why?
|
Luminescent Proteins | 1 | 2015 | 144 | 0.120 |
Why?
|
Plasmids | 1 | 2015 | 292 | 0.120 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 283 | 0.120 |
Why?
|
Intracellular Space | 2 | 2014 | 38 | 0.120 |
Why?
|
Heterozygote | 1 | 2015 | 373 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 2364 | 0.120 |
Why?
|
Protein Engineering | 1 | 2015 | 145 | 0.120 |
Why?
|
Cell Adhesion | 1 | 2015 | 429 | 0.120 |
Why?
|
Cohort Studies | 1 | 2021 | 2891 | 0.110 |
Why?
|
Cell Line | 4 | 2024 | 2505 | 0.110 |
Why?
|
Caveolin 3 | 1 | 2014 | 4 | 0.110 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 254 | 0.110 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 923 | 0.110 |
Why?
|
HIV Infections | 1 | 2023 | 852 | 0.110 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2013 | 136 | 0.110 |
Why?
|
Aged | 2 | 2021 | 19424 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 388 | 0.110 |
Why?
|
Cell Survival | 1 | 2015 | 987 | 0.110 |
Why?
|
Endosomes | 2 | 2010 | 81 | 0.100 |
Why?
|
Cytoskeleton | 1 | 2014 | 201 | 0.100 |
Why?
|
MicroRNAs | 1 | 2017 | 561 | 0.100 |
Why?
|
Cytoplasmic Vesicles | 1 | 2010 | 6 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2019 | 1991 | 0.090 |
Why?
|
Cardiotoxins | 1 | 2010 | 3 | 0.090 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 1 | 2009 | 4 | 0.090 |
Why?
|
Myoblasts, Skeletal | 1 | 2009 | 3 | 0.090 |
Why?
|
Myofibrils | 1 | 2009 | 23 | 0.080 |
Why?
|
Calcium Signaling | 1 | 2010 | 139 | 0.080 |
Why?
|
Models, Animal | 1 | 2010 | 278 | 0.080 |
Why?
|
Models, Biological | 1 | 2015 | 1770 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 2422 | 0.070 |
Why?
|
Endocytosis | 1 | 2008 | 184 | 0.070 |
Why?
|
RNA Splicing | 2 | 2019 | 158 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 961 | 0.070 |
Why?
|
Lamin Type A | 1 | 2006 | 26 | 0.070 |
Why?
|
HEK293 Cells | 2 | 2022 | 660 | 0.070 |
Why?
|
rab5 GTP-Binding Proteins | 1 | 2025 | 3 | 0.060 |
Why?
|
Ataxia | 1 | 2025 | 42 | 0.060 |
Why?
|
Annexin A2 | 1 | 2024 | 2 | 0.060 |
Why?
|
Decorin | 1 | 2024 | 6 | 0.060 |
Why?
|
Electrophysiological Phenomena | 1 | 2024 | 51 | 0.060 |
Why?
|
Cell Nucleus | 1 | 2006 | 605 | 0.060 |
Why?
|
Blood Proteins | 1 | 2024 | 149 | 0.060 |
Why?
|
Bortezomib | 1 | 2024 | 80 | 0.060 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2024 | 137 | 0.050 |
Why?
|
Cerebellum | 1 | 2025 | 250 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2024 | 201 | 0.050 |
Why?
|
Quantitative Trait Loci | 2 | 2019 | 615 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2006 | 728 | 0.050 |
Why?
|
Stress, Physiological | 1 | 2024 | 234 | 0.050 |
Why?
|
A549 Cells | 1 | 2022 | 44 | 0.050 |
Why?
|
Vero Cells | 1 | 2022 | 103 | 0.050 |
Why?
|
Pilot Projects | 1 | 2024 | 879 | 0.050 |
Why?
|
Proteomics | 1 | 2023 | 242 | 0.050 |
Why?
|
Antibodies, Blocking | 1 | 2021 | 22 | 0.050 |
Why?
|
Heart | 1 | 2024 | 580 | 0.050 |
Why?
|
Immunoassay | 1 | 2021 | 93 | 0.050 |
Why?
|
HeLa Cells | 1 | 2022 | 520 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2015 | 742 | 0.040 |
Why?
|
Anacardic Acids | 1 | 2019 | 1 | 0.040 |
Why?
|
Pulse Therapy, Drug | 1 | 2019 | 2 | 0.040 |
Why?
|
MEF2 Transcription Factors | 1 | 2019 | 10 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 314 | 0.040 |
Why?
|
Genetic Variation | 2 | 2019 | 1384 | 0.040 |
Why?
|
Histone Acetyltransferases | 1 | 2019 | 44 | 0.040 |
Why?
|
Residence Characteristics | 1 | 2021 | 201 | 0.040 |
Why?
|
Metabolomics | 1 | 2019 | 78 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2019 | 102 | 0.040 |
Why?
|
Disease Progression | 1 | 2023 | 1486 | 0.040 |
Why?
|
Epigenomics | 1 | 2019 | 103 | 0.040 |
Why?
|
Reading Frames | 1 | 2018 | 6 | 0.040 |
Why?
|
Survival Analysis | 1 | 2022 | 1500 | 0.040 |
Why?
|
Primary Cell Culture | 1 | 2018 | 77 | 0.040 |
Why?
|
Cellular Reprogramming | 1 | 2018 | 41 | 0.040 |
Why?
|
Annexin A1 | 1 | 2017 | 5 | 0.040 |
Why?
|
Urine | 1 | 2018 | 94 | 0.040 |
Why?
|
Transduction, Genetic | 1 | 2018 | 160 | 0.040 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2017 | 45 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 795 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2019 | 282 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 107 | 0.030 |
Why?
|
Muscular Atrophy | 1 | 2017 | 47 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 281 | 0.030 |
Why?
|
Neurons | 1 | 2025 | 1593 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2017 | 295 | 0.030 |
Why?
|
Recovery of Function | 1 | 2017 | 305 | 0.030 |
Why?
|
Receptors, Glucocorticoid | 1 | 2017 | 141 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2019 | 1074 | 0.030 |
Why?
|
Diaphragm | 1 | 2015 | 50 | 0.030 |
Why?
|
Codon, Nonsense | 1 | 2015 | 44 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 866 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 526 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2015 | 81 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2015 | 205 | 0.030 |
Why?
|
Fibroblasts | 1 | 2018 | 766 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2021 | 2782 | 0.030 |
Why?
|
Abdominal Muscles | 1 | 2014 | 19 | 0.030 |
Why?
|
Membranes | 1 | 2014 | 37 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 1738 | 0.030 |
Why?
|
Chromosomes, Mammalian | 1 | 2014 | 36 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 565 | 0.030 |
Why?
|
Organ Size | 1 | 2014 | 375 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2014 | 200 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2014 | 214 | 0.030 |
Why?
|
Time Factors | 1 | 2021 | 5366 | 0.030 |
Why?
|
Myocardium | 1 | 2015 | 574 | 0.030 |
Why?
|
Drosophila melanogaster | 1 | 2015 | 615 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 2015 | 510 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 558 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2014 | 792 | 0.020 |
Why?
|
Transferrin | 1 | 2008 | 21 | 0.020 |
Why?
|
Cell Fusion | 1 | 2008 | 39 | 0.020 |
Why?
|
Child | 1 | 2019 | 7219 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2008 | 211 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2008 | 354 | 0.020 |
Why?
|
Nuclear Envelope | 1 | 2006 | 38 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2006 | 97 | 0.020 |
Why?
|
Hydroxyproline | 1 | 2005 | 11 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 2077 | 0.010 |
Why?
|
Models, Molecular | 1 | 2008 | 1324 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 3030 | 0.010 |
Why?
|
Motor Activity | 1 | 2005 | 326 | 0.010 |
Why?
|